Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 1
2006 1
2007 4
2009 1
2011 2
2012 2
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling.
Laplantine E, Chable-Bessia C, Oudin A, Swain J, Soria A, Merida P, Gourdelier M, Mestiri S, Besseghe I, Bremaud E, Neyret A, Lyonnais S, Favard C, Benaroch P, Hubert M, Schwartz O, Guerin M, Danckaert A, Del Nery E, Muriaux D, Weil R. Laplantine E, et al. Among authors: chable bessia c. iScience. 2022 Oct 21;25(10):105066. doi: 10.1016/j.isci.2022.105066. Epub 2022 Sep 3. iScience. 2022. PMID: 36093378 Free PMC article.
Validation of flavivirus infectious clones carrying fluorescent markers for antiviral drug screening and replication studies.
Cherkashchenko L, Gros N, Trausch A, Neyret A, Hénaut M, Dubois G, Villeneuve M, Chable-Bessia C, Lyonnais S, Merits A, Muriaux D. Cherkashchenko L, et al. Among authors: chable bessia c. Front Microbiol. 2023 Sep 15;14:1201640. doi: 10.3389/fmicb.2023.1201640. eCollection 2023. Front Microbiol. 2023. PMID: 37779700 Free PMC article.
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
Bessis D, Trouillet-Assant S, Secco LP, Bardin N, Blanc B, Blatière V, Chable-Bessia C, Delfour C, Girard C, Richard JC, Gros N, Le Moing V, Molinari N, Pallure V, Pisoni A, Raison-Peyron N, Reynaud E, Schwob É, Pescarmona R, Samaran Q, Willems M, Vincent T, Sofonea MT, Belot A, Tuaillon É. Bessis D, et al. Among authors: chable bessia c. Br J Dermatol. 2022 Dec;187(6):1032-1035. doi: 10.1111/bjd.21820. Epub 2022 Sep 1. Br J Dermatol. 2022. PMID: 35971922 Free PMC article. No abstract available.
Suppression of HIV-1 replication by microRNA effectors.
Chable-Bessia C, Meziane O, Latreille D, Triboulet R, Zamborlini A, Wagschal A, Jacquet JM, Reynes J, Levy Y, Saib A, Bennasser Y, Benkirane M. Chable-Bessia C, et al. Retrovirology. 2009 Mar 9;6:26. doi: 10.1186/1742-4690-6-26. Retrovirology. 2009. PMID: 19272132 Free PMC article.
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells.
Descours B, Cribier A, Chable-Bessia C, Ayinde D, Rice G, Crow Y, Yatim A, Schwartz O, Laguette N, Benkirane M. Descours B, et al. Among authors: chable bessia c. Retrovirology. 2012 Oct 23;9:87. doi: 10.1186/1742-4690-9-87. Retrovirology. 2012. PMID: 23092122 Free PMC article.
Suppression of microRNA-silencing pathway by HIV-1 during virus replication.
Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M. Triboulet R, et al. Among authors: chable bessia c. Science. 2007 Mar 16;315(5818):1579-82. doi: 10.1126/science.1136319. Epub 2007 Feb 22. Science. 2007. PMID: 17322031
19 results